Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GHDX

Genomic Health (GHDX) Stock Price, News & Analysis

Genomic Health logo

About Genomic Health Stock (NASDAQ:GHDX)

Advanced Chart

Key Stats

Today's Range
$63.44
$63.44
50-Day Range
$63.44
$69.79
52-Week Range
$50.77
$90.18
Volume
N/A
Average Volume
1.05 million shs
Market Capitalization
$2.38 billion
P/E Ratio
60.42
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GHDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genomic Health and its competitors with MarketBeat's FREE daily newsletter.

GHDX Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
PanGenomic Health Announces CFO Transition
See More Headlines

GHDX Stock Analysis - Frequently Asked Questions

Genomic Health, Inc. (NASDAQ:GHDX) posted its quarterly earnings results on Monday, November, 11th. The medical research company reported $0.48 earnings per share for the quarter, topping analysts' consensus estimates of $0.37 by $0.11. Genomic Health had a net margin of 12.81% and a trailing twelve-month return on equity of 19.62%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genomic Health investors own include Revance Therapeutics (RVNC), Horizon Therapeutics Public (HZNP), Illumina (ILMN), NVIDIA (NVDA), Ionis Pharmaceuticals (IONS), Vertex Pharmaceuticals (VRTX) and Exelixis (EXEL).

Company Calendar

Last Earnings
11/11/2019
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Laboratories
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:GHDX
CIK
1131324
Fax
N/A
Employees
829
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$1.05
Trailing P/E Ratio
60.42
Forward P/E Ratio
40.15
P/E Growth
N/A
Net Income
$25.68 million
Net Margins
12.81%
Pretax Margin
N/A
Return on Equity
19.62%
Return on Assets
14.89%

Debt

Debt-to-Equity Ratio
0.15
Current Ratio
5.96
Quick Ratio
5.96

Sales & Book Value

Annual Sales
$394.11 million
Price / Sales
6.05
Cash Flow
$1.45 per share
Price / Cash Flow
43.76
Book Value
$7.48 per share
Price / Book
8.48

Miscellaneous

Outstanding Shares
37,590,000
Free Float
N/A
Market Cap
$2.38 billion
Optionable
Optionable
Beta
0.90
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:GHDX) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners